Spectral AI Inc (NASDAQ:MDAI), the wound care diagnostics specialist, has been included in the Russell Microcap Index following the annual Russell Reconstitution, which took effect after the market close on June 28, 2024. The reconstituted Russell Microcap Index will commence trading on July 1, 2024.
Spectral AI Inc (NASDAQ:MDAI) announced it surpassed 90% of its enrollment target for pediatric patients at burn centers for its late-stage study evaluating its AI-driven DeepView System. The company's DeepView System utilizes proprietary multispectral imaging to distinguish between healthy and damaged tissue and can be used upon a child's arrival at the emergency department or burn center to provide immediate and accurate wound assessments in support of timely clinical decision-making for burn injuries.
Spectral AI Inc (NASDAQ:MDAI) told investors that it has provided support to Nasdaq and the state securities authorities in Florida, Louisiana and Texas to bring their attention to the potential market manipulation of the company's stock, primarily in the form of naked short selling. The company said the inquiry is being led by Erich Spangenberg, a member of its board of directors and its largest shareholder.
Spectral AI Inc (NASDAQ:MDAI) announced that it has achieved 50% clinical trial site enrollment for its pivotal Deepview System study. The DeepView System's image processing algorithm uses multispectral imaging, which has been trained on a proprietary database of more than 340 billion data points, to aid healthcare providers in assessing the healing potential of a burn wound.
Spectral AI Inc (NASDAQ:MDAI) an artificial intelligence company specializing in medical diagnostics for wound care, is set to join the Russell Microcap Index. The Russell Microcap Index is designed to represent the microcap segment of the U.S.
Spectral AI Inc (NASDAQ:MDAI) announced that several of its officers and directors acquired approximately 113,000 shares of Spectral AI common stock in open market transactions in May. These transactions were made publicly and not through private arrangements, which can indicate confidence in the company's future prospects by its leadership.